Philippe Margaron

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

Iris Pharma SARL specializes in pre-clinical and clinical research in ophthalmology. The firm engages in drug discovery, ophthalmic preclinical development, and ophthalmic clinical development. The company was founded by Pierre-Paul Elena and is headquartered in La Gaude, Italy.

Charlesson LLC engages in the development of therapeutics for treating debilitating ophthalmic diseases. The firm product pipeline includes pharmaceutical treatments for age-related macular degeneration, diabetic retinopathy, ocular inflammation, angiogenesis, and systemic diabetes. The company was founded by Jian-Xing Ma and Yan Feng in 2003 and is headquartered in Oklahoma City, OK.